Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Greenrose Acquisition stock

Learn how to easily invest in Greenrose Acquisition stock.

Greenrose Acquisition Corp is a drug manufacturers-specialty & generic business based in the US. Greenrose Acquisition shares (GNRS) are listed on the OTCMKTS and all prices are listed in US Dollars. Greenrose Acquisition employs 91 staff and has a trailing 12-month revenue of around $26.8 million.

How to buy shares in Greenrose Acquisition

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – GNRS – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Greenrose Acquisition stock price (OTCMKTS: GNRS)

Use our graph to track the performance of GNRS stocks over time.

Greenrose Acquisition shares at a glance

Information last updated 2022-09-27.
Latest market close$1.50
52-week range$1.05 - $10.62
50-day moving average $2.11
200-day moving average $2.98
Wall St. target priceN/A
PE ratio 0.5651
Dividend yield $0 (0%)
Earnings per share (TTM) $3.10

Buy Greenrose Acquisition shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$0
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Public
Stocks, ETFs, Cryptocurrency
$0
$0
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Tradier
Stocks, Options, ETFs
$0
$0
N/A
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Greenrose Acquisition stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Greenrose Acquisition price performance over time

Historical closes compared with the close of $1.5 from 2022-09-28

1 week (2022-09-22) -14.77%
1 month (2022-08-29) -14.29%
3 months (2022-06-29) -40.59%
6 months (2022-03-29) -62.50%
1 year (2021-09-29) -85.10%
2 years (2020-09-29) -84.74%
3 years (2019-09-25) N/A
5 years (2017-09-25) N/A

Is Greenrose Acquisition stock undervalued or overvalued?

Valuing Greenrose Acquisition stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Greenrose Acquisition's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Greenrose Acquisition's P/E ratio

Greenrose Acquisition's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 1x. In other words, Greenrose Acquisition shares trade at around 1x recent earnings.

Greenrose Acquisition financials

Revenue TTM $26.8 million
Gross profit TTM $18.7 million
Return on assets TTM -10.71%
Return on equity TTM 189.14%
Profit margin 195.42%
Book value $2.85
Market capitalisation $30.9 million

TTM: trailing 12 months

Greenrose Acquisition share dividends

We're not expecting Greenrose Acquisition to pay a dividend over the next 12 months.

Greenrose Acquisition share price volatility

Over the last 12 months, Greenrose Acquisition's shares have ranged in value from as little as $1.05 up to $10.62. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (OTCMKTS average) beta is 1, while Greenrose Acquisition's is 0.1849. This would suggest that Greenrose Acquisition's shares are less volatile than average (for this exchange).

Greenrose Acquisition overview

Greenrose Holding Company Inc. , through its subsidiaries, engages in the production and sale of cannabis products. It engages in cultivating, processing, and packaging medical cannabis and derivative products. The company was founded in 2014 and is headquartered in Amityville, New York. .

Frequently asked questions

What percentage of Greenrose Acquisition is owned by insiders or institutions?
Currently 71.89% of Greenrose Acquisition shares are held by insiders and 18.499% by institutions.
How many people work for Greenrose Acquisition?
Latest data suggests 91 work at Greenrose Acquisition.
When does the fiscal year end for Greenrose Acquisition?
Greenrose Acquisition's fiscal year ends in December.
Where is Greenrose Acquisition based?
Greenrose Acquisition's address is: 111 Broadway, Amityville, NY, United States, 11701
What is Greenrose Acquisition's ISIN number?
Greenrose Acquisition's international securities identification number is: US3953921034
What is Greenrose Acquisition's CUSIP number?
Greenrose Acquisition's Committee on Uniform Securities Identification Procedures number is: 395392202

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site